EUVIMEDEUVIMED entdecken
Crossref

Low-Dose Lorazepam in the Treatment of Catatonia

Mollie C Marr, Matthew Staropoli, Paul Bonney, Joseph Chien

The Primary Care Companion For CNS Disorders · 03.11.2022 · 24 (6)

DOI: 10.4088/pcc.22cr03264 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Primary Care Companion For CNS Disorders, online erschienen am 03.11.2022. Verfasst von Mollie C Marr und 3 weiteren Autor:innen. Beteiligte Einrichtung: Oregon Health and Science University, Portland, Oregon. Hauptthemen laut MEDLINE: Lorazepam, Catatonia. Die Arbeit wurde bisher 2-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LorazepamCatatoniaHumans

Substanzen

Lorazepam

Autor:innen und Institutionen

  • Oregon Health and Science University, Portland, Oregon.
  • Corresponding author: Joseph Chien, DO, Oregon Health and Science University, 3181 SW Sam Jackson Park Rd, Portland, OR 97239 (jocn16@gmail.com).

Zitieren

APA

Marr, M. C., Staropoli, M., Bonney, P., & Chien, J. (2022). Low-Dose Lorazepam in the Treatment of Catatonia. The Primary Care Companion For CNS Disorders, 24(6). https://doi.org/10.4088/pcc.22cr03264

Vancouver

Marr MC, Staropoli M, Bonney P, Chien J. Low-Dose Lorazepam in the Treatment of Catatonia. The Primary Care Companion For CNS Disorders. 2022;24(6). doi:10.4088/pcc.22cr03264

BibTeX
@article{Marr2022,
  author = {Marr, Mollie C and Staropoli, Matthew and Bonney, Paul and Chien, Joseph},
  title = {Low-Dose Lorazepam in the Treatment of Catatonia},
  journal = {The Primary Care Companion For CNS Disorders},
  year = {2022},
  volume = {24},
  number = {6},
  doi = {10.4088/pcc.22cr03264}
}
Kostenlos starten →